Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00397943
Status:
COMPLETED
Last Update Posted:
2019-06-19
First Post:
2006-11-09
Brief Title:
Safety and Immunogenicity of 2 Formulations of Tuberculosis Vaccine GSK692342 Given at 01 Months to Healthy Adults
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-11-15
Start Date Type:
ACTUAL
Primary Completion Date:
2009-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2006-11-09
First Submit QC Date:
November 9 2006
Study First Post Date:
2006-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-08-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2012-03-09
Disp First Submit QC Date:
March 9 2012
Disp First Post Date:
2012-03-14
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2019-06-06
Last Update Post Date:
2019-06-19
Last Update Post Date Type:
ACTUAL